Glucocorticoid receptor and breast cancer Myriam VilascoLaudine CommunalAnne Gompel Review 05 August 2011 Pages: 1 - 10
Real-time elastography for the differentiation of benign and malignant breast lesions: a meta-analysis Xia GongQiuhua XuYazhu Chen Review 26 August 2011 Pages: 11 - 18
CAML promotes prolactin-dependent proliferation of breast cancer cells by facilitating prolactin receptor signaling pathways Ji-Hong LimTae-You KimJong-Wan Park Preclinical study 03 December 2010 Pages: 19 - 27
HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib Giorgio ValabregaSonia CapelleroFilippo Montemurro Preclinical study 09 December 2010 Pages: 29 - 40
A long AAAG repeat allele in the 5′ UTR of the ERR-γ gene is correlated with breast cancer predisposition and drives promoter activity in MCF-7 breast cancer cells C. L. GalindoJ. F. McCormickH. R. Garner Preclinical study 10 December 2010 Pages: 41 - 48
Role of CD200 expression in regulation of metastasis of EMT6 tumor cells in mice Reginald M. GorczynskiDavid A. ClarkIsmat Khatri Preclinical study 17 December 2010 Pages: 49 - 60
Oral administration of benzyl-isothiocyanate inhibits solid tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice Eun Ji KimJi Eun HongJung Han Yoon Park Preclinical study 18 December 2010 Pages: 61 - 71
Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells Nguyen Thi Thuy PhuongSang Kyum KimKeon Wook Kang Preclinical study 18 December 2010 Pages: 73 - 83
PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo Jin-gui MaHe HuangLing-hua Meng Preclinical study 22 December 2010 Pages: 85 - 96
Post-lumpectomy intracavitary retention and lymph node targeting of 99mTc-encapsulated liposomes in nude rats with breast cancer xenograft Shihong LiBeth GoinsAnde Bao Preclinical study 23 December 2010 Pages: 97 - 107
Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients Georg GöbelDoris AuerGünter Daxenbichler Preclinical study 08 January 2011 Pages: 109 - 117
Circulating free DNA: a new surrogate marker for minimal residual disease? Tanja FehmMalgorzata Banys Invited Commentary 15 February 2011 Pages: 119 - 122
SWOG S0215: a phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer Robert B. LivingstonWilliam E. BarlowGabriel N. Hortobagyi Clinical trial 09 August 2011 Pages: 123 - 131
Final overall survival results and effect of prolonged (≥1 year) first-line bevacizumab-containing therapy for metastatic breast cancer in the ATHENA trial Ian SmithJean-Yves PiergaKathleen I. Pritchard Clinical Trial 10 August 2011 Pages: 133 - 143
Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations Soley BayraktarAngelica M. Gutierrez-BarreraBanu K. Arun Clinical trial 10 August 2011 Pages: 145 - 153
First generation prognostic gene signatures for breast cancer predict both survival and chemotherapy sensitivity and identify overlapping patient populations Takayuki IwamotoJu-Seog LeeLajos Pusztai Clinical Trial 11 August 2011 Pages: 155 - 164
Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer Ying LiuMaria PérezDonna B. Jeffe Epidemiology 08 May 2011 Pages: 165 - 173
The association of reproductive factors and breastfeeding with long term survival from breast cancer Mirjam D. K. AlsakerSigne OpdahlLars J. Vatten Epidemiology 08 May 2011 Pages: 175 - 182
Associations of objectively assessed physical activity and sedentary time with biomarkers of breast cancer risk in postmenopausal women: findings from NHANES (2003–2006) Brigid M. LynchChristine M. FriedenreichNeville Owen Epidemiology 08 May 2011 Pages: 183 - 194
Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study Marilyn L. KwanHeather GreenleeBette J. Caan Epidemiology 11 May 2011 Pages: 195 - 205
Two new CHEK2 germ-line variants detected in breast cancer/sarcoma families negative for BRCA1, BRCA2, and TP53 gene mutations Siranoush ManoukianBernard PeisselDomenico Delia Epidemiology 12 May 2011 Pages: 207 - 215
Genotypes and phenotypes of IGF-I and IGFBP-3 in breast tumors among Chinese women Biyun QianHong ZhengKexin Chen Epidemiology 12 May 2011 Pages: 217 - 226
Does the effect of weight lifting on lymphedema following breast cancer differ by diagnostic method: results from a randomized controlled trial Sandra C. HayesRebecca M. SpeckKathryn H. Schmitz Epidemiology 12 May 2011 Pages: 227 - 234
Absenteeism and short-term disability associated with breast cancer Alex Z. FuLei ChenNeal P. Christiansen Epidemiology 13 May 2011 Pages: 235 - 242
Sleep duration change across breast cancer survivorship: associations with symptoms and health-related quality of life Catherine M. AlfanoKenneth L. LichsteinRachel Ballard-Barbash Epidemiology 13 May 2011 Pages: 243 - 254
Effect of primary prophylactic G-CSF use on systemic therapy administration for elderly breast cancer patients Suja S. RajanSally C. StearnsWilliam R. Carpenter Epidemiology 17 May 2011 Pages: 255 - 266
Detection of isolated ipsilateral regional lymph node recurrences by F18-fluorodeoxyglucose positron emission tomography–CT in follow-up of postoperative breast cancer patients Shozo OhsumiTakeshi InoueShigemitsu Takashima Epidemiology 13 May 2011 Pages: 267 - 272
Mothers’ pre-pregnancy BMI and weight gain during pregnancy and risk of breast cancer in daughters Kathryn M. WilsonWalter C. WillettKarin B. Michels Epidemiology 20 May 2011 Pages: 273 - 279
Pathological characteristics of BRCA-associated breast cancers in Hispanics Veronica I. Lagos-JaramilloMichael F. PressJeffrey N. Weitzel Epidemiology 21 May 2011 Pages: 281 - 289
Breast cancer risk assessment in women aged 70 and older Pamela M. VacekJoan M. SkellyBerta M. Geller Epidemiology 22 May 2011 Pages: 291 - 299
A SEER-Medicare population-based study of lymphedema-related claims incidence following breast cancer in men Anne S. ReinerLindsay M. JacksKatherine S. Panageas Brief Report 07 July 2011 Pages: 301 - 306
Insulin-like growth factor-1 receptor gene expression is associated with survival in breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression Peifen FuMutsuko IbusukiHirotaka Iwase Brief Report 12 July 2011 Pages: 307 - 317
Aberrant DNA methylation but not mutation of CITED4 is associated with alteration of HIF-regulated genes in breast cancer Katie T. HuangElena A. TakanoStephen B. Fox Brief Report 14 July 2011 Pages: 319 - 329
Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer Nobuyasu YoshimotoTatsuya ToyamaHiroko Yamashita Brief Report 14 July 2011 Pages: 331 - 339
Identification of a new complex rearrangement affecting exon 20 of BRCA1 Jesús del ValleOlga CamposConxi Lázaro Brief Report 15 July 2011 Pages: 341 - 344
Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era I. C. ChenC. H. LinA. L. Cheng Brief Report 27 July 2011 Pages: 345 - 351
Re Panoff et al., Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation Peter Graham Letter to the Editor 29 May 2011 Pages: 353 - 355
Polymorphisms of matrix metalloproteinases (MMP) gene and breast cancer risk: appraisal of a recent meta-analysis Xiao-Yang WuMin-Bin ChenWen-Xiang Shen Letter to the Editor 14 June 2011 Pages: 357 - 358
Detection of circulating tumor cells by RT-PCR significantly associated with poor prognosis in breast cancer Liling ZhangGang WuKlaus Pantel Letter to the Editor 21 June 2011 Pages: 359 - 364